Agios Pharmaceuticals Inc. (AGIO)
NASDAQ · Healthcare
Agios Pharmaceuticals Inc. EBITDA 2011–2025
Agios Pharmaceuticals Inc. annual/quarterly ebitda history and growth rate from 2017 to 2019. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Agios Pharmaceuticals Inc. annual ebitda for 2019 was -308.2 M, a 13.26% decrease from 2018.
- Agios Pharmaceuticals Inc. annual ebitda for 2018 was -355.3 M, a 13.02% increase from 2017.
- Agios Pharmaceuticals Inc. annual ebitda for 2017 was -314.4 M.
No data available.
Agios Pharmaceuticals Inc. EBITDA — FAQ
Agios Pharmaceuticals Inc. (AGIO) ebitda over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AGIO's ebitda history?
The chart and table above show Agios Pharmaceuticals Inc.'s ebitda by year and by quarter, including the growth rate.